Indicator Continued Discontinued New Schemes 2015/16 Access part 1 Continue – increase to a minimum of 13 appointments per 1000 patients daily Monday to Friday. Access part 2 Continue – decrease time commitment to 15 minutes per 1000 patients outside core hours. Practices to participate in the extended hours DES A+E x Exception Coding x Community Health MMR X Community Health Smear X Community Health MDT Meetings Continue as part of the frail elderly scheme Phlebotomy Continue Shared Care Continue – amendments in year 2015/16 Drug Administration Continue. Remove the need for patient questionnaires – amendments in year 2015/16 Data Validation Continue with changes - Data Review ABPI Continue Practice improvement Goal X Elderly x Identification and Care Planning EOL x SCHEDULE 2 – THE SERVICES
Service Specifications Service Specification No. 1 Service Primary Care Access Commissioner Lead Jan Leonard Provider Lead Practice Senior Partner Period Date of Review Annual 1. Population Needs National/local context and evidence base This Service Specification encourages practices to understand the impact that good patient access has on the healthcare system. Stakeholder engagement has identified from our partners (Healthwatch) that access for patients is a priority. Innovative access arrangements may have local value. 2. Outcomes 2.1 NHS Outcomes Framework Domains & Indicators 2.2 defined outcomes Everyone Counts Planning for Patients
Shared Care Appendix 1 Specified and Payment levels Level Payment Drug Indication Level 1 £500 fixed annual fee, based on average list size of 5,000 All shared-care drugs (except those listed in Level 2 and 3 below) regionally agreed by North West Medicines Management Alliance Guidelines on Prescribing Responsibilities for Red and Amber Medicines (RAG list) updated from time to time, as ratified by NHS Sefton Medicines Management Committee As per locally agreed shared care protocols Level 2 £60 per patient per Bicalutamide As per locally agreed shared care protocols Flutamide Cyproterone 3 £150 per patient per annum Azathioprine As per locally agreed shared care protocols Leflunomide Methotrexate Penicillamine Sodium Aurothiomalate Sulfasalazine Cyclosporin Mycophenolate Lithium As per locally agreed shared care protocols Low molecular weight heparin As per locally agreed shared care protocols The PDF shared care documents are currently being updated and can be accessed at: SCHEDULE 2 – THE SERVICES Service Specifications Service Specification No. 6 Service Drug Administration
2 Frail / Elderly Quarterly information as requested Last working day of the financial quarter Annual Practice Report DATE 3 Identification and Care Planning in End of Life (EOL) Quarterly information as requested Last working day of the financial quarter Annual Practice Report DATE 4 Phlebotomy Quarterly Invoice Last working day of the financial quarter Patient satisfaction Report (20 random samples) DATE 5 Shared Care Quarterly Invoice Last working day of financial quarter 6 Drug Administration Quarterly Invoice Last working day of financial quarter 7 Data Review Agreement of 3 local/QIPP priorities for internal clinical peer review – report and clinical external review at locality meeting 8 ABPI Quarterly invoice Last working day of the financial quarter Quarters outlined above reflect financial quarters where invoices are required SIGNATURE SHEET Practices stating an intention to participate must complete and return this signature sheet by DATE.